165 related articles for article (PubMed ID: 15649307)
1. Assessment of the cag pathogenicity island status of Helicobacter pylori infections with serology and PCR.
Kivi M; Tindberg Y; Bengtsson C; Engstrand L; Granström M
Clin Microbiol Infect; 2005 Jan; 11(1):66-8. PubMed ID: 15649307
[TBL] [Abstract][Full Text] [Related]
2. [Helicobacter pylori genotypes and their association with host's immune response].
Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051
[TBL] [Abstract][Full Text] [Related]
3. [High prevalence of VacA, CagA protein expression and presence of cag pathogenicity island in Japanese Helicobacter pylori isolates].
Omata M; Maeda S
Nihon Rinsho; 1999 Jan; 57(1):17-22. PubMed ID: 10036931
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.
Peters TM; Owen RJ; Slater E; Varea R; Teare EL; Saverymuttu S
J Clin Pathol; 2001 Mar; 54(3):219-23. PubMed ID: 11253135
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of the intact cag pathogenicity island in clinical isolates of Helicobacter pylori in Karachi, Pakistan.
Yakoob J; Jafri W; Abbas Z; Abid S; Khan R; Jafri N; Ahmad Z
Br J Biomed Sci; 2009; 66(3):137-42. PubMed ID: 19839224
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the cag pathogenicity island and IS605 of Helicobacter pylori strains isolated from patients with gastric cancer in Japan.
Deguchi R; Igarashi M; Watanabe K; Takagi A
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():13-6. PubMed ID: 15298600
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island.
Hsu PI; Hwang IR; Cittelly D; Lai KH; El-Zimaity HM; Gutierrez O; Kim JG; Osato MS; Graham DY; Yamaoka Y
Am J Gastroenterol; 2002 Sep; 97(9):2231-8. PubMed ID: 12358238
[TBL] [Abstract][Full Text] [Related]
8. The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations.
Kauser F; Khan AA; Hussain MA; Carroll IM; Ahmad N; Tiwari S; Shouche Y; Das B; Alam M; Ali SM; Habibullah CM; Sierra R; Megraud F; Sechi LA; Ahmed N
J Clin Microbiol; 2004 Nov; 42(11):5302-8. PubMed ID: 15528729
[TBL] [Abstract][Full Text] [Related]
9. Serological differentiation of Helicobacter pylori CagA(+) and CagA(-) infections.
Chmiela M; Wiśniewska M; Bak-Romaniszyn L; Rechciński T; Płaneta-Małecka I; Bielański W; Konturek SJ; Płonka M; Klink M; Rudnicka W
Arch Immunol Ther Exp (Warsz); 2003; 51(2):131-6. PubMed ID: 12776913
[TBL] [Abstract][Full Text] [Related]
10. The pattern of CagA and VacA proteins in Helicobacter pylori seropositive asymptomatic children in western Saudi Arabia.
Jaber SM
Saudi Med J; 2005 Sep; 26(9):1372-7. PubMed ID: 16155650
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction based analysis of the cytotoxin associated gene pathogenicity island of Helicobacter pylori from saliva: an approach for rapid molecular genotyping in relation to disease status.
Tiwari SK; Khan AA; Ahmed KS; Ali SM; Ahmed I; Habeeb A; Kauser F; Hussain MA; Ahmed N; Habibullah CM
J Gastroenterol Hepatol; 2005 Oct; 20(10):1560-6. PubMed ID: 16174074
[TBL] [Abstract][Full Text] [Related]
12. [The type IV secretion system encoded by the cag PAI of Helicobacter pylori].
Cui LL; Shao SH
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):743-5. PubMed ID: 17944386
[TBL] [Abstract][Full Text] [Related]
13. Genomic Comparison of cag pathogenicity island (PAI)-positive and -negative Helicobacter pylori strains: identification of novel markers for cag PAI-positive strains.
Terry CE; McGinnis LM; Madigan KC; Cao P; Cover TL; Liechti GW; Peek RM; Forsyth MH
Infect Immun; 2005 Jun; 73(6):3794-8. PubMed ID: 15908415
[TBL] [Abstract][Full Text] [Related]
14. Seminested polymerase chain reaction (PCR) for detecting Helicobacter pylori DNA in carotid atheromas.
Arias E; Martinetto H; Schultz M; Ameriso S; Rivera S; Lossetti O; Sevlever G
Diagn Mol Pathol; 2006 Sep; 15(3):174-9. PubMed ID: 16932074
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection.
Sozzi M; Tomasini ML; Vindigni C; Zanussi S; Tedeschi R; Basaglia G; Figura N; De Paoli P
J Lab Clin Med; 2005 Nov; 146(5):262-70. PubMed ID: 16242525
[TBL] [Abstract][Full Text] [Related]
16. Association between Helicobacter pylori genotypes and gastric disorders in relation to the cag pathogenicity island.
Proença Módena JL; Lopes Sales AI; Olszanski Acrani G; Russo R; Vilela Ribeiro MA; Fukuhara Y; da Silveira WD; Módena JL; de Oliveira RB; Brocchi M
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):7-16. PubMed ID: 17521839
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
[TBL] [Abstract][Full Text] [Related]
18. Detection of Helicobacter pylori cagA gene in gastric biopsies, clinical isolates and faeces.
Bindayna KM; Al Baker WA; Botta GA
Indian J Med Microbiol; 2006 Jul; 24(3):195-200. PubMed ID: 16912439
[TBL] [Abstract][Full Text] [Related]
19. The presence of the cag pathogenicity island is associated with increased superoxide anion radical scavenging activity by Helicobacter pylori.
Briedé JJ; Pot RG; Kuipers EJ; van Vliet AH; Kleinjans JC; Kusters JG
FEMS Immunol Med Microbiol; 2005 May; 44(2):227-32. PubMed ID: 15866220
[TBL] [Abstract][Full Text] [Related]
20. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis.
Annibale B; Lahner E; Santucci A; Vaira D; Pasquali A; Severi C; Mini R; Figura N; Delle Fave G
Helicobacter; 2007 Feb; 12(1):23-30. PubMed ID: 17241297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
